Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of alzheimer's disease
<p>Abstract</p> <p>Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a complementary marker for traditional clinical markers to improve diagnostic accuracy and also help in developing new pharmacotherapeutic trials. It has been revealed that l...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://www.diagnosticpathology.org/content/6/1/105 |